TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution – ETHealthworld.com
ETHealthworld.com |
TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution
ETHealthworld.com July 20, 2017, Mumbai: Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against … |
